In our study, women had in hypercholesterolemia trials made up 53 % of total patients,  similar to their share in the disease population. Globally, while there was difference in prevalence between various geographical locations, such difference was not found between the two sexes. A report based on the NHANES survey 1999-2000 on prevalence of dyslipidemia in diabetic patients, 71 % of males had LDL above goal while this was 79 % among females. In the same population in our study, women representation was only 37 % \cite{Jacobs_2005}.  In women with ACS and stable CAD, the representation was 21 % and 22 % respectively, while the disease prevalence among women in the US population was 41 % and 48 % respectively. Globally women make up 48 % of the CAD population. 
Racial and ethnic minorities make 39 % of the US population and are expected to reach 55 % by 2050 https://www.census.gov/data/tables/2017/demo/popproj/2017-summary-tables.html. Heart disease is the second leading cause of death for US Hispanics, responsible for 20.8 % of all deaths CDC. Hispanic - Latino - populations - racial - ethnic - minorities -minority health [internet] [cited 2015 Jul 16]. Available from: http://www.cdc.gov/minorityhealth/populations/REMP/hispanic.html#10. In a cohort free of CHD, there was no significant difference in the prevalence of dyslipidemia between blacks, Hispanics and non Hispanic whites. However the Hispanics were 20 % less likely to report drug therapy and blacks 15 % less likely . Also, these groups were 30 % less likely to have their lipids under control than their non Hispanic white counterparts \cite{Goff_2006}\cite{Leigh_2016}